var eventsData = [{"Ticker":"IR","EffectiveDate":"2017-02-10","Type":"RatingNeutral","Title":"Evercore ISI Group downgrades IR to Hold from Buy.","DailyReturn":"0.45%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"3.55%"},{"Ticker":"IR","EffectiveDate":"2017-02-01","Type":"EarningsMissRevenueBeat","Title":"Before market open, IR reports 2016 Q4's earning $0.84 per share and revenue $3359MM. This misses analyst's estimated EPS $0.92, beats estimated revenue $3350MM.","DailyReturn":"-1.7%","FiveDayReturnAfter":"0.62%","FiveDayReturnBefore":"-0.3%"},{"Ticker":"IR","EffectiveDate":"2016-12-07","Type":"Dividend","Title":"The Firm pays dividend $0.4","DailyReturn":"3.29%","FiveDayReturnAfter":"3.03%","FiveDayReturnBefore":"1.12%"},{"Ticker":"IR","EffectiveDate":"2016-11-16","Type":"RatingNeutral","Title":"Buckingham downgrades IR to Neutral from Buy.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.39%","FiveDayReturnBefore":"5.48%"},{"Ticker":"IR","EffectiveDate":"2016-10-26","Type":"EarningsRevenueBeat","Title":"Before market open, IR reports 2016 Q3's earning $1.41 per share and revenue $3568MM. This beats analyst's estimated EPS $1.28, beats estimated revenue $3550MM.","DailyReturn":"2.67%","FiveDayReturnAfter":"4.12%","FiveDayReturnBefore":"-0.55%"},{"Ticker":"IR","EffectiveDate":"2016-09-09","Type":"RatingNeutral","Title":"KeyBanc downgrades IR to Sector Weight from Overweight.","DailyReturn":"-6.39%","FiveDayReturnAfter":"-5.45%","FiveDayReturnBefore":"-0.37%"},{"Ticker":"IR","EffectiveDate":"2016-09-07","Type":"Dividend","Title":"The Firm pays dividend $0.32","DailyReturn":"0.88%","FiveDayReturnAfter":"-4.19%","FiveDayReturnBefore":"-2.67%"},{"Ticker":"IR","EffectiveDate":"2016-07-28","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains IR to Buy. Target Price is $75; previously $77.","DailyReturn":"1.28%","FiveDayReturnAfter":"2.58%","FiveDayReturnBefore":"-2.86%"},{"Ticker":"IR","EffectiveDate":"2016-07-27","Type":"EarningsBeatRevenueMiss","Title":"Before market open, IR reports 2016 Q2's earning $1.38 per share and revenue $3688MM. This beats analyst's estimated EPS $1.3, misses estimated revenue $3700MM.","DailyReturn":"-3.74%","FiveDayReturnAfter":"-2.76%","FiveDayReturnBefore":"1.56%"},{"Ticker":"IR","EffectiveDate":"2016-07-13","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on IR to Outperform.","DailyReturn":"0.86%","FiveDayReturnAfter":"0.25%","FiveDayReturnBefore":"5.93%"},{"Ticker":"IR","EffectiveDate":"2016-06-08","Type":"Dividend","Title":"The Firm pays dividend $0.32","DailyReturn":"0.48%","FiveDayReturnAfter":"-2.87%","FiveDayReturnBefore":"-1.46%"},{"Ticker":"IR","EffectiveDate":"2016-04-26","Type":"EarningsRevenueBeat","Title":"Before market open, IR reports 2016 Q1's earning $0.5 per share and revenue $2894MM. This beats analyst's estimated EPS $0.37, beats estimated revenue $2890MM.","DailyReturn":"2.12%","FiveDayReturnAfter":"3.24%","FiveDayReturnBefore":"0.2%"},{"Ticker":"IR","EffectiveDate":"2016-04-19","Type":"RatingNeutral","Title":"Citigroup maintains IR to Buy. Target Price is $72; previously $60.","DailyReturn":"-0.03%","FiveDayReturnAfter":"0.2%","FiveDayReturnBefore":"5.22%"},{"Ticker":"IR","EffectiveDate":"2016-04-14","Type":"RatingNeutral","Title":"Susquehanna maintains IR to Neutral. Target Price is $61; previously $55.","DailyReturn":"0.55%","FiveDayReturnAfter":"0.45%","FiveDayReturnBefore":"5.6%"},{"Ticker":"IR","EffectiveDate":"2016-04-14","Type":"RatingUpgrade","Title":"Buckingham Research upgrades IR to Buy from Neutral. Target Price is $71; previously $60.","DailyReturn":"0.55%","FiveDayReturnAfter":"0.45%","FiveDayReturnBefore":"5.6%"},{"Ticker":"IR","EffectiveDate":"2016-04-04","Type":"RatingNeutral","Title":"CLSA downgrades IR to Outperform from Buy.","DailyReturn":"-1.04%","FiveDayReturnAfter":"-2.82%","FiveDayReturnBefore":"1.29%"},{"Ticker":"IR","EffectiveDate":"2016-04-01","Type":"RatingNeutral","Title":"Goldman Sachs downgrades IR to Neutral from Buy.","DailyReturn":"0.11%","FiveDayReturnAfter":"-3.96%","FiveDayReturnBefore":"0.97%"},{"Ticker":"IR","EffectiveDate":"2016-03-28","Type":"RatingNeutral","Title":"Goldman Sachs downgrades IR to Neutral from Buy. Target Price is $64; previously $61.","DailyReturn":"0%","FiveDayReturnAfter":"1.29%","FiveDayReturnBefore":"0.45%"},{"Ticker":"IR","EffectiveDate":"2016-03-09","Type":"Dividend","Title":"The Firm pays dividend $0.32","DailyReturn":"0.75%","FiveDayReturnAfter":"3.04%","FiveDayReturnBefore":"0.17%"},{"Ticker":"IR","EffectiveDate":"2016-03-07","Type":"RatingUpgrade","Title":"Nomura upgrades IR to Buy from Neutral. Target Price is $68; previously $56.","DailyReturn":"1.53%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"1.54%"},{"Ticker":"IR","EffectiveDate":"2016-02-11","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains IR to Buy. Target Price is $61; previously $62.","DailyReturn":"-1.13%","FiveDayReturnAfter":"5.01%","FiveDayReturnBefore":"-0.8%"},{"Ticker":"IR","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Argus Research maintains IR to Buy. Target Price is $62; previously $72.","DailyReturn":"-1.19%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"2.72%"},{"Ticker":"IR","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $56; previously $60.","DailyReturn":"-1.19%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"2.72%"},{"Ticker":"IR","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Citigroup initiates coverage on IR to Buy.","DailyReturn":"-0.18%","FiveDayReturnAfter":"2.22%","FiveDayReturnBefore":"-6.71%"},{"Ticker":"IR","EffectiveDate":"2016-01-19","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $59; previously $53.","DailyReturn":"-2.24%","FiveDayReturnAfter":"-5.8%","FiveDayReturnBefore":"0.83%"},{"Ticker":"IR","EffectiveDate":"2015-12-09","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":"-0.21%","FiveDayReturnAfter":"-2.89%","FiveDayReturnBefore":"-6.33%"},{"Ticker":"IR","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains IR to Buy. Target Price is $64; previously $66.","DailyReturn":"2.21%","FiveDayReturnAfter":"4.13%","FiveDayReturnBefore":"5.47%"},{"Ticker":"IR","EffectiveDate":"2015-10-05","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $53; previously $69.","DailyReturn":"2.76%","FiveDayReturnAfter":"6.51%","FiveDayReturnBefore":"-2.17%"},{"Ticker":"IR","EffectiveDate":"2015-09-10","Type":"RatingNeutral","Title":"JP Morgan maintains IR to Overweight. Target Price is $71; previously $65.","DailyReturn":"0.05%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.8%"},{"Ticker":"IR","EffectiveDate":"2015-09-09","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":"1.23%","FiveDayReturnAfter":"5.23%","FiveDayReturnBefore":"-2.56%"},{"Ticker":"IR","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains IR to Buy. Target Price is $70; previously $77.","DailyReturn":"1.31%","FiveDayReturnAfter":"-2.19%","FiveDayReturnBefore":"-11.34%"},{"Ticker":"IR","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $69; previously $73.","DailyReturn":"1.31%","FiveDayReturnAfter":"-2.19%","FiveDayReturnBefore":"-11.34%"},{"Ticker":"IR","EffectiveDate":"2015-07-13","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $73; previously $70.","DailyReturn":"1.23%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"-1.64%"},{"Ticker":"IR","EffectiveDate":"2015-07-13","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades IR to Buy from Hold. Target Price is $77.","DailyReturn":"1.23%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"-1.64%"},{"Ticker":"IR","EffectiveDate":"2015-06-10","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":"1.27%","FiveDayReturnAfter":"1.07%","FiveDayReturnBefore":"-0.91%"},{"Ticker":"IR","EffectiveDate":"2015-05-22","Type":"RatingUpgrade","Title":"Argus Research upgrades IR to Buy from Hold. Target Price is $86.","DailyReturn":"-0.35%","FiveDayReturnAfter":"-1.07%","FiveDayReturnBefore":"-0.94%"},{"Ticker":"IR","EffectiveDate":"2015-05-14","Type":"RatingUpgrade","Title":"KeyBanc upgrades IR to Overweight from Sector Weight. Target Price is $80.","DailyReturn":"3.02%","FiveDayReturnAfter":"1.77%","FiveDayReturnBefore":"1.92%"},{"Ticker":"IR","EffectiveDate":"2015-04-24","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $70; previously $68.","DailyReturn":"-0.62%","FiveDayReturnAfter":"-4.77%","FiveDayReturnBefore":"0.37%"},{"Ticker":"IR","EffectiveDate":"2015-03-31","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $78; previously $75.","DailyReturn":"-0.54%","FiveDayReturnAfter":"-1.62%","FiveDayReturnBefore":"1.3%"},{"Ticker":"IR","EffectiveDate":"2015-03-17","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $68; previously $70.","DailyReturn":"-1.19%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"1.81%"},{"Ticker":"IR","EffectiveDate":"2015-03-11","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":"0.39%","FiveDayReturnAfter":"2.75%","FiveDayReturnBefore":"-1.82%"},{"Ticker":"IR","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $73; previously $70.","DailyReturn":"-0.36%","FiveDayReturnAfter":"0.28%","FiveDayReturnBefore":"2.65%"},{"Ticker":"IR","EffectiveDate":"2015-01-15","Type":"RatingNeutral","Title":"JP Morgan maintains IR to Overweight. Target Price is $71; previously $74.","DailyReturn":"0.19%","FiveDayReturnAfter":"5.24%","FiveDayReturnBefore":"0.39%"},{"Ticker":"IR","EffectiveDate":"2014-12-10","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.66%","FiveDayReturnAfter":"-3.12%","FiveDayReturnBefore":"-0.15%"},{"Ticker":"IR","EffectiveDate":"2014-11-25","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on IR to Sector Perform. Target Price is $67.","DailyReturn":"0.1%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"1.97%"},{"Ticker":"IR","EffectiveDate":"2014-10-28","Type":"RatingNeutral","Title":"JP Morgan maintains IR to Overweight. Target Price is $74; previously $73.","DailyReturn":"3.02%","FiveDayReturnAfter":"2.67%","FiveDayReturnBefore":"5.16%"},{"Ticker":"IR","EffectiveDate":"2014-10-23","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $73; previously $64.","DailyReturn":"3.93%","FiveDayReturnAfter":"6.27%","FiveDayReturnBefore":"6.8%"},{"Ticker":"IR","EffectiveDate":"2014-10-07","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades IR to Buy from Neutral. Target Price is $68; previously $67.","DailyReturn":"-1.27%","FiveDayReturnAfter":"-5.62%","FiveDayReturnBefore":"-1.03%"},{"Ticker":"IR","EffectiveDate":"2014-09-17","Type":"RatingNeutral","Title":"Stifel initiates coverage on IR to Hold. Target Price is $63.","DailyReturn":"-0.31%","FiveDayReturnAfter":"-3.47%","FiveDayReturnBefore":"0.97%"},{"Ticker":"IR","EffectiveDate":"2014-09-10","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.68%","FiveDayReturnAfter":"0.97%","FiveDayReturnBefore":"-0.81%"},{"Ticker":"IR","EffectiveDate":"2014-09-05","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on IR to Neutral. Target Price is $65.","DailyReturn":"0.46%","FiveDayReturnAfter":"1.1%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"IR","EffectiveDate":"2014-08-19","Type":"RatingNeutral","Title":"Baird downgrades IR to Neutral from Outperform. Target Price is $65; previously $68.","DailyReturn":"-1.01%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"2.98%"},{"Ticker":"IR","EffectiveDate":"2014-08-07","Type":"RatingUpgrade","Title":"ISI Group upgrades IR to Buy from Neutral. Target Price is $66; previously $62.","DailyReturn":"0.63%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-4.01%"},{"Ticker":"IR","EffectiveDate":"2014-07-23","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $73; previously $70.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"4.61%"},{"Ticker":"IR","EffectiveDate":"2014-07-23","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $64; previously $62.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"4.61%"},{"Ticker":"IR","EffectiveDate":"2014-07-23","Type":"RatingNeutral","Title":"Citigroup maintains IR to Neutral. Target Price is $65; previously $64.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"4.61%"},{"Ticker":"IR","EffectiveDate":"2014-07-23","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $65; previously $61.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-5.28%","FiveDayReturnBefore":"4.61%"},{"Ticker":"IR","EffectiveDate":"2014-06-24","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on IR to Neutral. Target Price is $70.","DailyReturn":"-1.42%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"0.42%"},{"Ticker":"IR","EffectiveDate":"2014-06-11","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.81%","FiveDayReturnAfter":"0.49%","FiveDayReturnBefore":"5.82%"},{"Ticker":"IR","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $70; previously $69.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"7.41%"},{"Ticker":"IR","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Citigroup maintains IR to Hold. Target Price is $64; previously $61.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"7.41%"},{"Ticker":"IR","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $62; previously $57.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"7.41%"},{"Ticker":"IR","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $61; previously $58.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"7.41%"},{"Ticker":"IR","EffectiveDate":"2014-04-22","Type":"RatingUpgrade","Title":"Bank of America upgrades IR to Buy.","DailyReturn":"0.55%","FiveDayReturnAfter":"1.44%","FiveDayReturnBefore":"5.85%"},{"Ticker":"IR","EffectiveDate":"2014-03-12","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.05%","FiveDayReturnAfter":"-1.79%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"IR","EffectiveDate":"2014-02-11","Type":"EarningsRelease","Title":"Before market open, IR reports 2013 Q4's earning $0.61 per share and revenue $3100MM. This meets analyst's estimated EPS $0.61, beats estimated revenue $3030MM.","DailyReturn":"-3.08%","FiveDayReturnAfter":"0.5%","FiveDayReturnBefore":"3.84%"},{"Ticker":"IR","EffectiveDate":"2014-01-16","Type":"RatingNeutral","Title":"Citigroup maintains IR to Neutral. Target Price is $62; previously $64.","DailyReturn":"0.06%","FiveDayReturnAfter":"-3.51%","FiveDayReturnBefore":"1.58%"},{"Ticker":"IR","EffectiveDate":"2013-12-09","Type":"RatingNeutral","Title":"MKM Partners downgrades IR to Neutral from Buy.","DailyReturn":"0.21%","FiveDayReturnAfter":"0.22%","FiveDayReturnBefore":"-0.62%"},{"Ticker":"IR","EffectiveDate":"2013-12-03","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $50; previously $62.","DailyReturn":"0.84%","FiveDayReturnAfter":"2.22%","FiveDayReturnBefore":"1.04%"},{"Ticker":"IR","EffectiveDate":"2013-11-13","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $77; previously $73.","DailyReturn":"-0.33%","FiveDayReturnAfter":"-0.22%","FiveDayReturnBefore":"0.36%"},{"Ticker":"IR","EffectiveDate":"2013-11-13","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $52; previously $64.","DailyReturn":"-0.33%","FiveDayReturnAfter":"-0.22%","FiveDayReturnBefore":"0.36%"},{"Ticker":"IR","EffectiveDate":"2013-10-30","Type":"Dividend","Title":"The Firm pays dividend $0.16773","DailyReturn":"-1.07%","FiveDayReturnAfter":"-0.44%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"IR","EffectiveDate":"2013-10-18","Type":"EarningsMissRevenueBeat","Title":"Before market open, IR reports 2013 Q3's earning $0.57 per share and revenue $3750MM. This misses analyst's estimated EPS $1.1, beats estimated revenue $3730MM.","DailyReturn":"5.24%","FiveDayReturnAfter":"6.29%","FiveDayReturnBefore":"-1.73%"},{"Ticker":"IR","EffectiveDate":"2013-09-11","Type":"RatingUpgrade","Title":"JP Morgan upgrades IR to Overweight from Neutral.","DailyReturn":"-1.13%","FiveDayReturnAfter":"0.2%","FiveDayReturnBefore":"6.83%"},{"Ticker":"IR","EffectiveDate":"2013-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.16773","DailyReturn":"-1.13%","FiveDayReturnAfter":"0.2%","FiveDayReturnBefore":"6.83%"},{"Ticker":"IR","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"ISI Group downgrades IR to Neutral from Strong Buy.","DailyReturn":"-0.92%","FiveDayReturnAfter":"-2.2%","FiveDayReturnBefore":"-0.85%"},{"Ticker":"IR","EffectiveDate":"2013-07-22","Type":"RatingNeutral","Title":"Morgan Stanley maintains IR to Equal-Weight. Target Price is $65; previously $62.","DailyReturn":"-2%","FiveDayReturnAfter":"-2.9%","FiveDayReturnBefore":"6.32%"},{"Ticker":"IR","EffectiveDate":"2013-07-19","Type":"EarningsRevenueBeat","Title":"Before market open, IR reports 2013 Q2's earning $1.14 per share and revenue $3930MM. This beats analyst's estimated EPS $1.08, beats estimated revenue $3890MM.","DailyReturn":"5.05%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"1.51%"},{"Ticker":"IR","EffectiveDate":"2013-06-12","Type":"Dividend","Title":"The Firm pays dividend $0.16773","DailyReturn":"-0.95%","FiveDayReturnAfter":"2.05%","FiveDayReturnBefore":"-0.72%"},{"Ticker":"IR","EffectiveDate":"2013-05-09","Type":"RatingNeutral","Title":"Buckingham Research downgrades IR to Neutral from Buy. Target Price is $59.","DailyReturn":"0.63%","FiveDayReturnAfter":"2.45%","FiveDayReturnBefore":"6.1%"},{"Ticker":"IR","EffectiveDate":"2013-04-23","Type":"EarningsBeatRevenueMiss","Title":"Before market open, IR reports 2013 Q1's earning $0.42 per share and revenue $3110MM. This beats analyst's estimated EPS $0.4, misses estimated revenue $3160MM.","DailyReturn":"-1.01%","FiveDayReturnAfter":"0.44%","FiveDayReturnBefore":"0.44%"},{"Ticker":"IR","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Citigroup maintains IR to Neutral. Target Price is $58; previously $54.","DailyReturn":"-0.63%","FiveDayReturnAfter":"0.21%","FiveDayReturnBefore":"1.96%"},{"Ticker":"IR","EffectiveDate":"2013-03-08","Type":"Dividend","Title":"The Firm pays dividend $0.16773","DailyReturn":"1.49%","FiveDayReturnAfter":"4.17%","FiveDayReturnBefore":"2.01%"},{"Ticker":"IR","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $65; previously $57.","DailyReturn":"-1.06%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"1.71%"},{"Ticker":"IR","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $47; previously $43.","DailyReturn":"-1.06%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"1.71%"},{"Ticker":"IR","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $57; previously $55.","DailyReturn":"-1.06%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"1.71%"},{"Ticker":"IR","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"UBS maintains IR to Buy. Target Price is $58; previously $54.","DailyReturn":"-1.06%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"1.71%"},{"Ticker":"IR","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $57; previously $53.","DailyReturn":"-1.06%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"1.71%"},{"Ticker":"IR","EffectiveDate":"2013-01-11","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $57; previously $55.","DailyReturn":"-0.04%","FiveDayReturnAfter":"2.64%","FiveDayReturnBefore":"1.33%"},{"Ticker":"IR","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"Wells Fargo downgrades IR to Market Perform from Outperform.","DailyReturn":"-1.56%","FiveDayReturnAfter":"-0.34%","FiveDayReturnBefore":"5.55%"},{"Ticker":"IR","EffectiveDate":"2013-01-02","Type":"RatingUpgrade","Title":"ISI Group upgrades IR to Buy from Hold. Target Price is $59; previously $51.","DailyReturn":"3.14%","FiveDayReturnAfter":"2.61%","FiveDayReturnBefore":"1.78%"},{"Ticker":"IR","EffectiveDate":"2012-12-12","Type":"Dividend","Title":"The Firm pays dividend $0.1278","DailyReturn":"0.44%","FiveDayReturnAfter":"1.56%","FiveDayReturnBefore":"-0.43%"},{"Ticker":"IR","EffectiveDate":"2012-12-11","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $53; previously $51.","DailyReturn":"-0.31%","FiveDayReturnAfter":"-0.58%","FiveDayReturnBefore":"-0.35%"},{"Ticker":"IR","EffectiveDate":"2012-12-10","Type":"RatingNeutral","Title":"Bank of America maintains IR to Neutral. Target Price is $54; previously $48.","DailyReturn":"-1.84%","FiveDayReturnAfter":"-1.92%","FiveDayReturnBefore":"-0.18%"},{"Ticker":"IR","EffectiveDate":"2012-12-07","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $51; previously $47.","DailyReturn":"1.01%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-0.97%"},{"Ticker":"IR","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $43; previously $40.","DailyReturn":"0.43%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"4.5%"},{"Ticker":"IR","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"Citigroup maintains IR to Neutral. Target Price is $48; previously $42.","DailyReturn":"0.43%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"4.5%"},{"Ticker":"IR","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"Nomura maintains IR to Neutral. Target Price is $45; previously $43.","DailyReturn":"0.43%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"4.5%"},{"Ticker":"IR","EffectiveDate":"2012-10-19","Type":"EarningsBeatRevenueMiss","Title":"After market close, IR reports 2012 Q3's earning $1.09 per share and revenue $3590MM. This beats analyst's estimated EPS $0.98, misses estimated revenue $3650MM.","DailyReturn":"1.51%","FiveDayReturnAfter":"1.58%","FiveDayReturnBefore":"2.84%"},{"Ticker":"IR","EffectiveDate":"2012-10-15","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $55; previously $50.","DailyReturn":"0.4%","FiveDayReturnAfter":"4.5%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"IR","EffectiveDate":"2012-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.1278","DailyReturn":"0.54%","FiveDayReturnAfter":"0%","FiveDayReturnBefore":"-1.87%"},{"Ticker":"IR","EffectiveDate":"2012-09-04","Type":"RatingNeutral","Title":"Bank of America downgrades IR to Neutral from Buy. Target Price is $48.","DailyReturn":"-1.94%","FiveDayReturnAfter":"-1.87%","FiveDayReturnBefore":"-0.34%"},{"Ticker":"IR","EffectiveDate":"2012-08-28","Type":"RatingNeutral","Title":"UBS maintains IR to Buy. Target Price is $54; previously $45.","DailyReturn":"-0.04%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.83%"},{"Ticker":"IR","EffectiveDate":"2012-08-03","Type":"RatingNeutral","Title":"ISI Group downgrades IR to Hold from Buy.","DailyReturn":"1.52%","FiveDayReturnAfter":"6.39%","FiveDayReturnBefore":"4.78%"},{"Ticker":"IR","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Barclays maintains IR to Equal-Weight. Target Price is $40; previously $39.","DailyReturn":"0.24%","FiveDayReturnAfter":"5.25%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"IR","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Credit Suisse maintains IR to Outperform. Target Price is $44; previously $43.","DailyReturn":"0.24%","FiveDayReturnAfter":"5.25%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"IR","EffectiveDate":"2012-07-20","Type":"EarningsBeatRevenueMiss","Title":"IR reports 2012 Q2's earning $1.14 per share and revenue $3820MM. This beats analyst's estimated EPS $0.91, misses estimated revenue $3890MM.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-3.6%","FiveDayReturnBefore":"4.51%"},{"Ticker":"IR","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"Bank of America maintains IR to Buy. Target Price is $48; previously $50.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-3.6%","FiveDayReturnBefore":"4.51%"},{"Ticker":"IR","EffectiveDate":"2012-06-14","Type":"Dividend","Title":"The Firm pays dividend $0.1278","DailyReturn":"-0.73%","FiveDayReturnAfter":"0.83%","FiveDayReturnBefore":"-2.02%"},{"Ticker":"IR","EffectiveDate":"2012-05-10","Type":"RatingNeutral","Title":"Bank oferica maintains IR to Buy. Target Price is $50; previously $46.","DailyReturn":"-2.06%","FiveDayReturnAfter":"-5.53%","FiveDayReturnBefore":"4.8%"},{"Ticker":"IR","EffectiveDate":"2012-05-09","Type":"RatingNeutral","Title":"Morgan Stanley maintains IR to Overweight. Target Price is $49.","DailyReturn":"5.37%","FiveDayReturnAfter":"1.22%","FiveDayReturnBefore":"-2.17%"},{"Ticker":"IR","EffectiveDate":"2012-04-24","Type":"RatingNeutral","Title":"UBS maintains IR to Buy. Target Price is $45; previously $42.","DailyReturn":"3.03%","FiveDayReturnAfter":"5.51%","FiveDayReturnBefore":"1.78%"},{"Ticker":"IR","EffectiveDate":"2012-04-20","Type":"EarningsRelease","Title":"Before market open, IR reports 2012 Q1's earning $0.31 per share and revenue $3150MM..","DailyReturn":"1.19%","FiveDayReturnAfter":"3.42%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"IR","EffectiveDate":"2012-03-15","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $50; previously $45.","DailyReturn":"1.21%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"5.47%"},{"Ticker":"IR","EffectiveDate":"2012-03-15","Type":"RatingNeutral","Title":"Morgan Stanley maintains IR to Overweight. Target Price is $45; previously $43.","DailyReturn":"1.21%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"5.47%"},{"Ticker":"IR","EffectiveDate":"2012-03-12","Type":"RatingNeutral","Title":"Jefferies maintains IR to Buy. Target Price is $45; previously $44.","DailyReturn":"1.96%","FiveDayReturnAfter":"4.58%","FiveDayReturnBefore":"-0.74%"},{"Ticker":"IR","EffectiveDate":"2012-03-08","Type":"Dividend","Title":"The Firm pays dividend $0.1278","DailyReturn":"2.74%","FiveDayReturnAfter":"5.47%","FiveDayReturnBefore":"-3.88%"},{"Ticker":"IR","EffectiveDate":"2012-02-10","Type":"RatingNeutral","Title":"Bank oferica maintains IR to Buy. Target Price is $46; previously $40.","DailyReturn":"0.13%","FiveDayReturnAfter":"7.48%","FiveDayReturnBefore":"4.5%"},{"Ticker":"IR","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"UBS maintains IR to Buy. Target Price is $42; previously $41.","DailyReturn":"-0.15%","FiveDayReturnAfter":"3.26%","FiveDayReturnBefore":"7.68%"}];